Systemic Therapy in Combination with Stereotactic Radiotherapy in Patients with Metastatic Colorectal Cancer Up to 10 Metastatic Sites

NCT05375708 · clinicaltrials.gov ↗

PHASE2

Phase

SUSPENDED

Status

93

Enrollment

OTHER

Sponsor class

Stopped Pilot study findings pointed to a overhaul in study design

Conditions

Metastatic Colorectal Cancer
Oligometastatic Disease

Interventions

RADIATION: Stereotactic body radiation therapy (SBRT)
DRUG: Maintenance therapy (CAP-B or 5-FU/LV plus bevacizumab.)

Sponsor

UMC Utrecht